L606

· Pharmosa Biopharm Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for L606, covering 2025-08-05 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD [Phase 3]